Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$0.31 - $0.55 $4,092 - $7,260
-13,200 Reduced 48.35%
14,100 $7,000
Q1 2023

May 15, 2023

BUY
$0.32 - $1.88 $4,192 - $24,628
13,100 Added 92.25%
27,300 $9,000
Q4 2022

Feb 14, 2023

SELL
$0.35 - $20.75 $1,085 - $64,325
-3,100 Reduced 17.92%
14,200 $5,000
Q3 2022

Nov 14, 2022

SELL
$0.83 - $21.25 $3,403 - $87,125
-4,100 Reduced 19.16%
17,300 $11,000

About Vivos Therapeutics, Inc.


  • Ticker VVOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 23,012,100
  • Market Cap $78.2M
  • Description
  • Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dent...
More about VVOS
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.